"Visit the UCLA Health website for coronavirus updates."

During the past decade, Jonsson Comprehensive Cancer Center, UCLA conducted 161 clinical trials. In the 10-year time frame, 161 clinical trials started and 92 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 59 clinical trials started and 35 clinical trials were completed. i.e. 59.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jonsson Comprehensive Cancer Center, UCLA" #1 sponsor was "Jonsson Comprehensive Cancer Center" with 251 trials, followed by "Children's Oncology Group" with 73 trials sponsored, "SWOG Cancer Research Network" with 62 trials sponsored, "National Cancer Institute (NCI)" with 61 trials sponsored and "Gynecologic Oncology Group" with 61 trials sponsored. Other sponsors include 213 different institutions and companies that sponsored additional 91 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jonsson Comprehensive Cancer Center, UCLA" #1 collaborator was "National Cancer Institute (NCI)" with 421 trials as a collaborator, "SWOG Cancer Research Network" with 20 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Bristol-Myers Squibb" with 12 trials as a collaborator and "Cancer and Leukemia Group B" with 11 trials as a collaborator. Other collaborators include 223 different institutions and companies that were collaborators in the rest 123 trials.

According to Clinical.Site data, the most researched conditions in "Jonsson Comprehensive Cancer Center, UCLA" are "Leukemia" (63 trials), "Lymphoma" (54 trials), "Breast Cancer" (45 trials), "Lung Cancer" (44 trials) and "Brain and Central Nervous System Tumors" (40 trials). Many other conditions were trialed in "Jonsson Comprehensive Cancer Center, UCLA" in a lesser frequency.

Most popular intervention types in "Jonsson Comprehensive Cancer Center, UCLA" are "Drug" (512 trials), "Biological" (202 trials), "Procedure" (194 trials), "Other" (175 trials) and "Radiation" (158 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (75 trials), "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (49 trials), "filgrastim" (49 trials) and "Questionnaire Administration" (48 trials). Other intervention names were less common.

The vast majority of trials in "Jonsson Comprehensive Cancer Center, UCLA" are 523 trials for "All" genders, 142 trials for "Female" genders and 60 trials for "Male" genders.

Currently, there are NaN active trials in "Jonsson Comprehensive Cancer Center, UCLA". 3 are not yet recruiting, 57 are recruiting, 81 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 440 completed trials in Jonsson Comprehensive Cancer Center, UCLA, 6 suspended trials, and 73 terminated clinical trials to date.

Out of the total trials that were conducted in Jonsson Comprehensive Cancer Center, UCLA, 175 "Phase 1" clinical trials were conducted, 321 "Phase 2" clinical trials and 166 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 74 trials that are defined as “Not Applicable".